Because these medications affect the way the body digests food, they can also cause disruptive gastrointestinal side effects, including a loss of appetite, stomach upset, nausea, vomiting, or diarrhea
On testing the sample, Turner found GIP to be 100 times more potent in stimulating insulin secretion in hyperglycaemic rats than his preparation of IRP (Marks 2020)
Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice
Compounded medications are prepared by licensed pharmacies and are not FDA-approved
Effects of Glucagon Like Peptide-1 Receptor Agonists on Endocrine Metabolism Interestingly, GLP-1RAs not only exert a protective effect on the nervous and cardiovascular systems, but also exhibit a regulatory effect on metabolism